ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 13 of 44
Up
JMBS 2022, 7(3): 99–105
https://doi.org/10.26693/jmbs07.03.099
Clinical Medicine

Genetics of Mucopolysaccharidosis Type IV (Morquio Disorder) in Patients from Azerbaijan

Alizada Sevda Aydin 1, Aliyeva Kamila Ali Agha 2, Musayev Shirkhan Aftandil 3, Rasulov Elkhan Mammed Rasul 3
Abstract

Genetic screening in the Azerbaijan Republic for mucopolysaccharidosis disorder has been implemented. The purpose of the work was to study types of mucopolysaccharidosis mutations and discuss ways of disorder prophylaxis in the family with parents of reproductive ages. Materials and methods. Material for studies was collected in the specialized children medical centers in Baku city, Azerbaijan, as well as in the field works in the regions of the Republic for 2018–2022. Patients were chosen during clinical examinations by pediatrician and geneticist. To screen mucopolysaccharidosis disorder a complex of modern molecular-genetic diagnostics methods have been applied. 56 patients were identified in the age varied between six months and 28 years. Gender differentiation was as follows: 15 males and 11 females. Blood sampling was done onto dry blood sample cards. All patients have undergone enzyme analysis for all mucopolysaccharidosis types. Results and discussion. The carried-out screening of enzymatic analysis allowed us to identify 26 patients with the N-aсetylgalaсtosamine-6-sulfat sulfatase enzyme deficit out of disorder suspicious 56 persons. And that was specific for mucopolysaccharidosis type IV A. That counted 46.4% of all studied patients. Seven mutation types in homozygous, double heterozygous (compound) and heterozygous state were identified. All mutations have nucleotide substitution. Practical application of the results is being discussed. Mucopolysaccharidosis type IV frequency was higher than other mucopolysaccharidosis disorder types. In eight patients the level of the enzyme was very low and varied between <0.1 (LOD) μmol/L/h and <0.3 (LOD) μmol/L/h, which is specific for homozygous or double heterozygous state, when norm is ≥2.0 mol/L/h. In 18 patients the activity level of N-aсetylgalaсtosamine-6-sulfate sulfatase enzyme was almost half reduced (<0.6 (LOD) μmol/L/h - <0.1 (LOD)), which speaks to heterozygous state of disorder. Conclusion. Thus, for the first time populational study of mucopolysaccharidosis disorder by means of molecular-genetic modern complex has been carried out. Molecular-genetic analysis allowed our identification of 7 GALNS gene mutation types: 553 C>T, 439 T>A, 1283 A>G, 157 G>A, 463 G-T, 1018 G-T and 443 A>G. These mutations have nucleotide substitutions and have been priory described in references

Keywords: storage disorder, N-acetylgalactosamine-6-sulfate sulfatase, β-galactosidase, MPS IVA enzyme, gene, mucopolysaccharidosis, autosomal-recessive inheritance type

Full text: PDF (Eng) 265K

References
  1. Morquio L. Sur une forme de dystrophie osseuse familiale. Archives de médecine des infants. Paris. 1929;32:129-135. [French]
  2. Tomatsu S, Fukuda S, Masue M, Sukegawa K, Fukao T, Yamagishi A, et al. Morquio disease: isolation, characterization and expression of full - length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun. 1991 Dec 16;181(2):677-83. PMID: 1755850. https://doi.org/10.1016/0006-291X(91)91244-7
  3. Fukuda S, Tomatsu S, Masuno M, Ogawa T, Yamagishi A, Rezvi GM, et al. Mucopolysaccharidosis IVA: submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical Morquio disease. Hum Mutat. 1996;7(2):123-34. PMID: 8829629. https://doi.org/10.1002/(SICI)1098-1004(1996)7:2<123::AID-HUMU6>3.0.CO;2-D
  4. Hori T, Tomatsu S, Nakashima Y, Uchiyama A, Fukuda S, Sukegawa K, et al. Mucopolysaccharidosis type IVA: common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS). Genomics. 1995 Apr 10;26(3):535-42. PMID: 7607677. https://doi.org/10.1016/0888-7543(95)80172-I
  5. Tomatsu S, Fukuda S, Cooper A, Wraith James E, Ferreira P, Di Natale P, et al. Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene. Hum Mutat. 1997;10(5):368-375. PMID: 9375852. https://doi.org/10.1002/(SICI)1098-1004(1997)10:5<368::AID-HUMU6>3.0.CO;2-B
  6. Tomatsu S, Fukuda S, Masue M, Sukegawa K, Masuno M, Orii T. Mucopolysaccharidosis type IVA: characterization and chromosomal localization of N-acetylgalactosamine-6-sulfate sulfatase gene and genetic heterogeneity. Am J Hum Genet. 1992;51(suppl):A178.
  7. Tomatsu S, Montano AM, Oikawa H, Dung VC, Hashimoto A, Oguma T, et al. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions? Mol Genet Metab. 2015 Feb;114(2):195-202. PMID: 24953405. PMCID: PMC4256128. https://doi.org/10.1016/j.ymgme.2014.05.013
  8. Masuno M, Tomatsu S, Nakashima Y, Hori T, Fukuda S, Masue M, et al. Mucopolysaccharidosis IVA: assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to chromosome 16q24. Genomics. 1993 Jun;16(3):777-8. PMID: 8325655. https://doi.org/10.1006/geno.1993.1266
  9. Morís F, Gotor V. Selective aminoacylation of nucleosides through an enzymatic reaction with oxime aminoacyl esters. Tetrahedron. 1994;50(23):6927-6934. https://doi.org/10.1016/S0040-4020(01)81345-4
  10. Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017 July;121(3):227-240. PMID: 28595941. PMCID: PMC5653283. https://doi.org/10.1016/j.ymgme.2017.05.016
  11. Guest JD, Rao A, Olson L, Bunge MB, Bunge RP. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp Neurol. 1997 Dec;148(2):502-22. PMID: 9417829. https://doi.org/10.1016/exnr.1997.6693
  12. Sukegawa K, Nakamura H, Kato Z, Tomatsus S, Montano AM, Fukao T, et al. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Molec Genet. 2000 May 22;9(9):1283-90. PMID: 10814710.https://doi.org/10.1093/hmg/9.9.1283
  13. Terzioglu M, Tokatli A, Coskun T, Emre S. Molecular analysis of Turkish MPS IVA (Morqiuo A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene. Hum Mutat. 2002 Dec;20(6):477-8. PMID: 12442278. https://doi.org/10.1002/humu.9088
  14. Puckett Y, Mallorga-Hernández A, Montaño AM. Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities. Orphanet J Rare Dis. 2021 May 29;16(1):241. PMID: 34051828. PMCID: PMC8164808. https://doi.org/10.1186/s13023-021-01880-8
  15. Jurecka A, Ługowska A, Golda A, Czartoryska B, Tylki-Szymańska A. Prevalence rates of mucopolysaccharidoses in Poland. J Appl Genet. 2015 May;56(2):205-210. PMID: 25472774. PMCID: PMC4412687. https://doi.org/10.1007/s13353-014-0262-5
  16. Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017 May;121(3):227-240. PMID: 28595941. PMCID: PMC5653283. https://doi.org/10.1016/j.ymgme.2017.05.016
  17. Khedhiri S, Chkioua L, Elcioglu N, Laradi S, Miled A. Mutations and polymorphisms in N-acetylgalactosamine-6-sulfate sulfatase gene in Turkish Morquio A patients. Pathol Biol (Paris). 2014 Feb;62(1):38-40. PMID: 24411403. https://doi.org/10.1016/j.patbio.2013.10.001
  18. Chkioua L. Genetic Heterogeneity of 72 Patients with Mucopolysaccharidosis in Tunisia. Int J New Technol Res. 2015 Jul;1(3):01-06.
  19. Rivera-Colón Y, Schutsky EK, Kita AZ, Garman SC. The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IVA. J Mol Biol. 2012 Nov 9;423(5):736-51. PMID: 22940367. PMCID: PMC3472114. https://doi.org/10.1016/j.jmb.2012.08.020
  20. Chuang CK, Lee CL, Tu RY, Lo YT, Sisca F, Chang YH, et al. Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the "Gold Standard" Criteria Required to Make a Confirmatory Diagnosis. Diagnostics (Basel). 2021 Aug 31;11(9):1583. PMID: 34573925. PMCD: PMC8465393. https://doi.org/10.3390/diagnostics11091583
  21. Yana E, Amboro FYP, Nurisman E, Hadiyati N. The Role Of The Polri In The Law Enforcement Of The Distribution Of Hate Speech In The City Of Batam, Indonesia. Ganesha Law Rev. 2021;3(1). https://doi.org/10.23887/glr.v3i1.321
  22. Pasieka A. Hierarchy and pluralism: Living religious difference in Catholic Poland. Palgrave Macmillan New York; 2015. 261 p.
  23. https://doi.org/10.1057/9781137482860
  24. Chan EYY, Chiu CP, Chan GKW. Medical and health risks associated with communicable diseases of Rohingya refugees in Bangladesh 2017. Int J Infect Dis. 2018 Mar;68:39-43. PMID: 29329951. https://doi.org/10.1016/j.ijid.2018.01.001